BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34811734)

  • 1. Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography for staging of canine insulinoma: 3 cases (2019-2020).
    Walczak R; Kawalilak L; Griffin L
    J Small Anim Pract; 2022 Mar; 63(3):227-233. PubMed ID: 34811734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging canine patients with appendicular osteosarcoma utilizing fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography.
    Brody A; Crooks JC; French JM; Lang LG; Randall EK; Griffin LR
    Vet Comp Oncol; 2022 Sep; 20(3):541-550. PubMed ID: 35166445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography as an effective method for staging in dogs with primary appendicular osteosarcoma.
    Crooks C; Randall E; Griffin L
    Vet Radiol Ultrasound; 2021 May; 62(3):350-359. PubMed ID: 33629412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study utilizing Fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography for glycolytic phenotyping of canine mast cell tumors.
    Griffin LR; Thamm DH; Selmic LE; Ehrhart EJ; Randall E
    Vet Radiol Ultrasound; 2018 Jul; 59(4):461-468. PubMed ID: 29570234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of triple-phase computed tomography in dogs with pancreatic insulinoma.
    Fukushima K; Fujiwara R; Yamamoto K; Kanemoto H; Ohno K; Tsuboi M; Uchida K; Matsuki N; Nishimura R; Tsujimoto H
    J Vet Med Sci; 2016 Jan; 77(12):1549-53. PubMed ID: 26118410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early
    Leroy-Freschini B; Amodru V; Addeo P; Sebag F; Vix M; Brunaud L; Klein M; Bahougne T; Bachellier P; Castinetti F; Goichot B; Chevalier E; Taieb D; Imperiale A
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):686-695. PubMed ID: 30617961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of accuracy for
    Willcox JL; Spriet M; Zwingenberger AL; Phillips KL; Burton JH; Skorupski KA; Hansen KS; Affolter VK; Woolard KD; Beylin D; Giuffrida MA
    Vet Comp Oncol; 2021 Sep; 19(3):463-472. PubMed ID: 32892513
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Grobman M; Cohn L; Knapp S; Bryan JN; Reinero C
    Vet Radiol Ultrasound; 2018 Jan; 59(1):107-115. PubMed ID: 28925085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (
    Matsumoto T; Okabe H; Yamashita YI; Yusa T; Itoyama R; Nakao Y; Yamao T; Umzaki N; Tsukamoto M; Kitano Y; Miyata T; Arima K; Nitta H; Hayashi H; Imai K; Chikamoto A; Baba H
    Surg Today; 2019 Jan; 49(1):21-26. PubMed ID: 30128759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of metabolic tumour volume and total lesion glycolysis for dogs staged for appendicular osteosarcoma with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Griffin LR; Brody A; Lee BI
    Vet Comp Oncol; 2022 Mar; 20(1):59-68. PubMed ID: 33988286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of use of fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography (
    Slinkard PT; Randall EK; Griffin LR
    Can J Vet Res; 2021 Apr; 85(2):131-136. PubMed ID: 33883821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of contrast-enhanced computed tomography in the evaluation of canine insulinoma location.
    Buishand FO; Vilaplana Grosso FR; Kirpensteijn J; van Nimwegen SA
    Vet Q; 2018 Dec; 38(1):53-62. PubMed ID: 29806550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDOPA PET/CT imaging of insulinoma revisited.
    Imperiale A; Sebag F; Vix M; Castinetti F; Kessler L; Moreau F; Bachellier P; Guillet B; Namer IJ; Mundler O; Taïeb D
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):409-18. PubMed ID: 25367749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The appearance of canine insulinoma on dual phase computed tomographic angiography.
    Coss P; Gilman O; Warren-Smith C; Major AC
    J Small Anim Pract; 2021 Jul; 62(7):540-546. PubMed ID: 33769568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of fluorine
    Griffin LR; Thamm DH; Brody A; Selmic LE
    J Vet Intern Med; 2019 Mar; 33(2):820-826. PubMed ID: 30768736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmed and presumed canine insulinomas and their presumed metastases are most conspicuous in the late arterial phase in a triple arterial phase CT protocol.
    Skarbek A; Fouriez-Lablée V; Dirrig H; Llabres-Diaz F
    Vet Radiol Ultrasound; 2023 Sep; 64(5):834-843. PubMed ID: 37496364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.